140 related articles for article (PubMed ID: 2957596)
1. Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration.
Guirguis R; Margulies I; Taraboletti G; Schiffmann E; Liotta L
Nature; 1987 Sep 17-23; 329(6136):261-3. PubMed ID: 2957596
[TBL] [Abstract][Full Text] [Related]
2. Expression of autocrine motility factor/phosphohexose isomerase in Cos7 cells.
Lagana A; Duchaine T; Raz A; DesGroseillers L; Nabi IR
Biochem Biophys Res Commun; 2000 Jun; 273(1):213-8. PubMed ID: 10873589
[TBL] [Abstract][Full Text] [Related]
3. Nucleokinesis: distinct pattern of cell translocation in response to an autocrine motility factor-like substance or fibronectin.
Klominek J; Sundqvist KG; Robért KH
Proc Natl Acad Sci U S A; 1991 May; 88(9):3902-6. PubMed ID: 1902574
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer cell motility is promoted by 14-3-3γ.
Hiraoka E; Mimae T; Ito M; Kadoya T; Miyata Y; Ito A; Okada M
Breast Cancer; 2019 Sep; 26(5):581-593. PubMed ID: 30830684
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells.
Kohn EC; Francis EA; Liotta LA; Schiffmann E
Int J Cancer; 1990 Aug; 46(2):287-92. PubMed ID: 2116998
[TBL] [Abstract][Full Text] [Related]
6. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells.
Shankar J; Messenberg A; Chan J; Underhill TM; Foster LJ; Nabi IR
Cancer Res; 2010 May; 70(9):3780-90. PubMed ID: 20388789
[TBL] [Abstract][Full Text] [Related]
7. Autocrine motility factor and its receptor: role in cell locomotion and metastasis.
Nabi IR; Watanabe H; Raz A
Cancer Metastasis Rev; 1992 Mar; 11(1):5-20. PubMed ID: 1324804
[TBL] [Abstract][Full Text] [Related]
8. New challenges in pseudopodial proteomics by a laser-assisted cell etching technique.
Mimae T; Ito A
Biochim Biophys Acta; 2015 Jun; 1854(6):538-46. PubMed ID: 25461796
[TBL] [Abstract][Full Text] [Related]
9. Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.
Hijazi MM; Thompson EW; Tang C; Coopman P; Torri JA; Yang D; Mueller SC; Lupu R
Int J Oncol; 2000 Oct; 17(4):629-41. PubMed ID: 10995872
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell autocrine motility factor receptor.
Nabi IR; Watanabe H; Silletti S; Raz A
EXS; 1991; 59():163-77. PubMed ID: 1655517
[TBL] [Abstract][Full Text] [Related]
11. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Yanagawa T; Funasaka T; Tsutsumi S; Watanabe H; Raz A
Endocr Relat Cancer; 2004 Dec; 11(4):749-59. PubMed ID: 15613449
[TBL] [Abstract][Full Text] [Related]
12. Biochemical mechanisms of tumor invasion and metastases.
Liotta LA; Wewer U; Rao NC; Schiffmann E; Stracke M; Guirguis R; Thorgeirsson U; Muschel R; Sobel M
Adv Exp Med Biol; 1988; 233():161-9. PubMed ID: 2851925
[TBL] [Abstract][Full Text] [Related]
13. Albumin marks pseudopodia of astrocytoma cells responding to hepatocyte growth factor or serum.
Beckner ME; Zhang Z; Agostino NR; Day BW; Pollack IF
Lab Invest; 2006 Nov; 86(11):1103-14. PubMed ID: 16969371
[TBL] [Abstract][Full Text] [Related]
14. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
[TBL] [Abstract][Full Text] [Related]
15. Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jul; 285(1):118-28. PubMed ID: 11437381
[TBL] [Abstract][Full Text] [Related]
16. Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jun; 284(5):1116-25. PubMed ID: 11414699
[TBL] [Abstract][Full Text] [Related]
17. Rho/ROCK-dependent pseudopodial protrusion and cellular blebbing are regulated by p38 MAPK in tumour cells exhibiting autocrine c-Met activation.
Jia Z; Vadnais J; Lu ML; Noël J; Nabi IR
Biol Cell; 2006 Jun; 98(6):337-51. PubMed ID: 16448388
[TBL] [Abstract][Full Text] [Related]
18. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
[TBL] [Abstract][Full Text] [Related]
19. Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cells.
Kohn EC; Liotta LA; Schiffmann E
Biochem Biophys Res Commun; 1990 Jan; 166(2):757-64. PubMed ID: 2154219
[TBL] [Abstract][Full Text] [Related]
20. The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects.
Kathagen-Buhmann A; Maire CL; Weller J; Schulte A; Matschke J; Holz M; Ligon KL; Glatzel M; Westphal M; Lamszus K
Neuro Oncol; 2018 Nov; 20(12):1594-1605. PubMed ID: 30053149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
